Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.
Condition: Autism Spectrum Disorder (ASD) Interventions: Drug: BUMETANIDE/S95008; Drug: PLACEBO Sponsors: Institut de Recherches Internationales Servier; ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials
Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder
Condition: Autism Spectrum Disorder (ASD) Interventions: Drug: Bumetanide Oral Solution; Drug: Placebo Sponsors: Institut de Recherches Internationales Servier; ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials
Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.
Condition: Autism Spectrum Disorder (ASD) Interventions: Drug: BUMETANIDE/S95008; Drug: PLACEBO Sponsors: Institut de Recherches Internationales Servier; ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials
Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder
Condition: Autism Spectrum Disorder (ASD) Interventions: Drug: Bumetanide Oral Solution; Drug: Placebo Sponsors: Institut de Recherches Internationales Servier; ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials
Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.
Condition: Autism Spectrum Disorder (ASD) Interventions: Drug: BUMETANIDE/S95008; Drug: PLACEBO Sponsors: Institut de Recherches Internationales Servier; ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials
Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder
Condition: Autism Spectrum Disorder (ASD) Interventions: Drug: Bumetanide Oral Solution; Drug: Placebo Sponsors: Institut de Recherches Internationales Servier; ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials
Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.
Condition: Autism Spectrum Disorder (ASD) Interventions: Drug: BUMETANIDE/S95008; Drug: PLACEBO Sponsors: Institut de Recherches Internationales Servier; ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials
Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder
Condition: Autism Spectrum Disorder (ASD) Interventions: Drug: Bumetanide Oral Solution; Drug: Placebo Sponsors: Institut de Recherches Internationales Servier; ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials
Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.
Condition: Autism Spectrum Disorder (ASD) Interventions: Drug: BUMETANIDE/S95008; Drug: PLACEBO Sponsors: Institut de Recherches Internationales Servier; ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 22, 2018 Category: Research Source Type: clinical trials
A Study of Bumetanide for the Treatment of Autism Spectrum Disorders
Condition: Autism Spectrum Disorder Interventions: Drug: Bumetanide; Drug: Placebo Sponsors: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of Medicine Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2017 Category: Research Source Type: clinical trials
